{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:57:24Z","timestamp":1789199844961,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pcad.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:29:18Z","timestamp":1749554958000},"page":"130-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC)"],"prefix":"10.1016","volume":"91","author":[{"given":"Benjamin M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Roston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Laksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0005","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCEP.111.964577","article-title":"Brugada syndrome","volume":"5","author":"Mizusawa","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","article-title":"Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome","volume":"138","author":"Hosseini","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","article-title":"Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility","volume":"54","author":"Barc","year":"2022","journal-title":"Nat Genet"},{"issue":"37","key":"10.1016\/j.pcad.2025.06.002_bb0025","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/eurheartj\/ehz435","article-title":"Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores","volume":"40","author":"Tadros","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0030","first-page":"665","article-title":"J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"19","author":"Antzelevitch","year":"2017","journal-title":"Europace"},{"issue":"15","key":"10.1016\/j.pcad.2025.06.002_bb0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2021.08.010","article-title":"Biventricular myocardial fibrosis and sudden death in patients with Brugada syndrome","volume":"78","author":"Miles","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.pcad.2025.06.002_bb0040","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","article-title":"Electroanatomic and pathologic right ventricular outflow tract abnormalities in patients With Brugada syndrome","volume":"72","author":"Pieroni","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.pcad.2025.06.002_bb0045","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"10.1016\/j.pcad.2025.06.002_bb0050","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/eurheartj\/ehaa383","article-title":"An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.pcad.2025.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jacc.2018.02.022","article-title":"Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome","volume":"71","author":"Pappone","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.pcad.2025.06.002_bb0060","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.122.063367","article-title":"Long-term outcomes of Brugada substrate ablation: a report from BRAVO (Brugada ablation of VF substrate ongoing multicenter registry)","volume":"147","author":"Nademanee","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehaa1051","article-title":"Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?","volume":"42","author":"Behr","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0070","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2019.01.026","article-title":"Comparison of ajmaline and procainamide provocation tests in the diagnosis of Brugada syndrome","volume":"5","author":"Cheung","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.pcad.2025.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.hrthm.2015.03.015","article-title":"High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia","volume":"12","author":"Hasdemir","year":"2015","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacep.2022.05.003","article-title":"Use of wearable technology and deep learning to improve the diagnosis of Brugada syndrome","volume":"8","author":"Liao","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"20","key":"10.1016\/j.pcad.2025.06.002_bb0085","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.123.064689","article-title":"Asymptomatic patients with Brugada ECG pattern: long-term prognosis from a large prospective study","volume":"148","author":"Gaita","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacep.2020.08.032","article-title":"A primary prevention clinical risk score model for patients with Brugada syndrome (BRUGADA-RISK)","volume":"7","author":"Honarbakhsh","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"issue":"5 Pt A","key":"10.1016\/j.pcad.2025.06.002_bb0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.hrthm.2019.11.027","article-title":"Age at diagnosis of Brugada syndrome: influence on clinical characteristics and risk of arrhythmia","volume":"17","author":"Minier","year":"2020","journal-title":"Heart Rhythm"},{"issue":"22","key":"10.1016\/j.pcad.2025.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A score model to predict risk of events in patients with Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019788","article-title":"Does the age of sudden cardiac death in family members matter in Brugada syndrome?","volume":"10","author":"Rattanawong","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005222","article-title":"Age of first arrhythmic event in Brugada syndrome: data from the SABRUS (survey on arrhythmic events in Brugada syndrome) in 678 patients","volume":"10","author":"Milman","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0120","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurheartj\/ehaa942","article-title":"Brugada syndrome genetics is associated with phenotype severity","volume":"42","author":"Ciconte","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.pcad.2025.06.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020767","article-title":"Standard ECG in Brugada syndrome as a marker of prognosis: from risk stratification to pathophysiological insights","volume":"10","author":"Vitali","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0130","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.hrthm.2017.02.026","article-title":"Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications","volume":"14","author":"Gray","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2025.06.002_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.089","article-title":"Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome","volume":"277","author":"Castro Hevia","year":"2019","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2025.06.002_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.hrthm.2021.08.034","article-title":"Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: a United Kingdom single-center experience","volume":"19","author":"Scrocco","year":"2022","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.pcad.2025.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehaa763","article-title":"Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome","volume":"42","author":"Probst","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.pcad.2025.06.002_bb0160","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.hrthm.2023.06.013","article-title":"Predicting arrhythmic event score in Brugada syndrome: worldwide pooled analysis with internal and external validation","volume":"20","author":"Rattanawong","year":"2023","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0165","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/europace\/eup114","article-title":"Drug-induced Brugada syndrome","volume":"11","author":"Yap","year":"2009","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0170","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/joa3.12227","article-title":"Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: insights into syncope after drinking alcohol","volume":"35","author":"Wu","year":"2019","journal-title":"J Arrhythm"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacep.2018.09.005","article-title":"Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada syndrome","volume":"5","author":"Dereci","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0180","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"issue":"13","key":"10.1016\/j.pcad.2025.06.002_bb0185","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0190","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0195","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations: a randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0200","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0205","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","article-title":"Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review","volume":"15","author":"Fernandes","year":"2018","journal-title":"Heart Rhythm"},{"issue":"18","key":"10.1016\/j.pcad.2025.06.002_bb0210","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0215","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","article-title":"Long-QT syndrome: from genetics to management","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0220","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","article-title":"An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome","volume":"141","author":"Adler","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.120.045956","article-title":"Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome","volume":"142","author":"Lahrouchi","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2025.06.002_bb0230","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.121.055783","article-title":"Polymorphic ventricular tachycardia: terminology, mechanism, diagnosis, and emergency therapy","volume":"144","author":"Viskin","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/nyas.14425","article-title":"Targeting the beta-adrenergic receptor in the clinical management of congenital long QT syndrome","volume":"1474","author":"Saadeh","year":"2020","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007571","article-title":"R-from-T as a common mechanism of arrhythmia initiation in long QT syndromes","volume":"12","author":"Liu","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"32","key":"10.1016\/j.pcad.2025.06.002_bb0245","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehac135","article-title":"Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond","volume":"43","author":"Odening","year":"2022","journal-title":"Eur Heart J"},{"issue":"40","key":"10.1016\/j.pcad.2025.06.002_bb0250","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0255","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/heartjnl-2020-318259","article-title":"Diagnosis, management and therapeutic strategies for congenital long QT syndrome","volume":"108","author":"Wilde","year":"2022","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.pcad.2025.06.002_bb0260","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.118.033943","article-title":"Determination and interpretation of the QT interval","volume":"138","author":"Vink","year":"2018","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.pcad.2025.06.002_bb0265","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/CIRCULATIONAHA.120.048916","article-title":"Exercise training-induced repolarization abnormalities masquerading as congenital long QT syndrome","volume":"142","author":"Dagradi","year":"2020","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.pcad.2025.06.002_bb0270","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.pcad.2025.06.002_bb0275","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.111.028258","article-title":"Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands","volume":"124","author":"Sy","year":"2011","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.pcad.2025.06.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025108","article-title":"Sex differences and utility of treadmill testing in long-QT syndrome","volume":"11","author":"Yee","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0285","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamacardio.2020.7422","article-title":"Use of artificial intelligence and deep neural networks in evaluation of patients with electrocardiographically concealed long QT syndrome from the surface 12-lead electrocardiogram","volume":"6","author":"Bos","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamacardio.2024.0039","article-title":"Deep learning-augmented ECG analysis for screening and genotype prediction of congenital long QT syndrome","volume":"9","author":"Jiang","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0295","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2022.11.036","article-title":"Phenotypes of overdiagnosed long QT syndrome","volume":"81","author":"Bains","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.pcad.2025.06.002_bb0300","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2025.06.002_bb0310","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCULATIONAHA.120.048250","article-title":"Sex-related differences in cardiac channelopathies: implications for clinical practice","volume":"143","author":"Asatryan","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0315","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/europace\/euac013","article-title":"Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-authors' reply","volume":"24","author":"Mazzanti","year":"2022","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.pcad.2025.06.002_bb0320","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","article-title":"Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene","volume":"115","author":"Moss","year":"2007","journal-title":"Circulation"},{"issue":"46","key":"10.1016\/j.pcad.2025.06.002_bb0325","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1093\/eurheartj\/ehab582","article-title":"Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region","volume":"42","author":"Schwartz","year":"2021","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.pcad.2025.06.002_bb0330","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021088","article-title":"Risk prediction in women with congenital long QT syndrome","volume":"10","author":"Goldenberg","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0335","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028902","article-title":"Risk prediction in male adolescents with congenital long QT syndrome: implications for sex-specific risk stratification in potassium channel-mediated long QT syndrome","volume":"13","author":"Bjelic","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.pcad.2025.06.002_bb0340","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2020.02.017","article-title":"Intentional nontherapy in long QT syndrome","volume":"17","author":"MacIntyre","year":"2020","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0345","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2021.04.026","article-title":"Return-to-play for athletes with long QT syndrome or genetic heart diseases predisposing to sudden death","volume":"78","author":"Tobert","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0350","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.hrthm.2017.12.020","article-title":"Exercise participation and shared decision-making in patients with inherited channelopathies and cardiomyopathies","volume":"15","author":"Etheridge","year":"2018","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0355","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent?","volume":"14","author":"Ackerman","year":"2017","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10840-016-0161-2","article-title":"Experience with bisoprolol in long-QT1 and long-QT2 syndrome","volume":"47","author":"Steinberg","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0365","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.hrthm.2023.11.007","article-title":"Type 3 long QT syndrome: is the effectiveness of treatment with beta-blockers population-specific?","volume":"21","author":"Hermida","year":"2024","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0370","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2025.06.002_bb0375","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"10.1016\/j.pcad.2025.06.002_bb0385","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.jacc.2021.09.017","article-title":"Effectiveness of implantable cardioverter-defibrillators to reduce mortality in patients with long QT syndrome","volume":"78","author":"Wang","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0390","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacep.2021.09.002","article-title":"Left cardiac sympathetic denervation for long QT syndrome: 50 years' experience provides guidance for management","volume":"8","author":"Dusi","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"16","key":"10.1016\/j.pcad.2025.06.002_bb0395","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehx394","article-title":"Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model","volume":"39","author":"Mehta","year":"2018","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.pcad.2025.06.002_bb0400","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehz023","article-title":"From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome type 2","volume":"40","author":"Schwartz","year":"2019","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.pcad.2025.06.002_bb0405","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.120.051836","article-title":"Suppression-replacement KCNQ1 gene therapy for type 1 long QT syndrome","volume":"143","author":"Dotzler","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pcad.2025.06.002_bb0410","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehab687","article-title":"Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death","volume":"43","author":"Walsh","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0415","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"issue":"20","key":"10.1016\/j.pcad.2025.06.002_bb0420","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC focus seminar 5\/5","volume":"77","author":"Priori","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0425","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.116.001424","article-title":"Yield of the RYR2 genetic test in suspected catecholaminergic polymorphic ventricular tachycardia and implications for test interpretation","volume":"11","author":"Kapplinger","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"10","key":"10.1016\/j.pcad.2025.06.002_bb0430","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patterns, arrhythmic risks, and underlying mechanisms of CASQ2-catecholaminergic polymorphic ventricular tachycardia","volume":"142","author":"Ng","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0435","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.119.039711","article-title":"Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0440","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0445","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/europace\/euac177","article-title":"Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia","volume":"25","author":"Peltenburg","year":"2023","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0450","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacep.2021.02.013","article-title":"Burst exercise testing can unmask arrhythmias in patients with incompletely penetrant catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Roston","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0455","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.hrthm.2021.07.061","article-title":"Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Kallas","year":"2021","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0460","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamacardio.2022.0219","article-title":"Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with beta-blockers","volume":"7","author":"Mazzanti","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0465","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacep.2016.01.020","article-title":"Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: a single center's early experience","volume":"2","author":"Ostby","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"issue":"25","key":"10.1016\/j.pcad.2025.06.002_bb0470","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.123.064786","article-title":"Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"148","author":"Bergeman","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2025.06.002_bb0475","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.pcad.2025.06.002_bb0480","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.pcad.2025.06.002_bb0485","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.pcad.2025.06.002_bb0490","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0495","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCEP.113.000170","article-title":"Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate","volume":"6","author":"Miyake","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"10.1016\/j.pcad.2025.06.002_bb0500","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.hrthm.2024.04.006","article-title":"An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Lamba","year":"2024","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca(2+)\/calmodulin-dependent kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.pcad.2025.06.002_bb0510","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1093\/eurheartj\/ehad418","article-title":"Clinical presentation of calmodulin mutations: the international calmodulinopathy registry","volume":"44","author":"Crotti","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0515","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002419","article-title":"International triadin knockout syndrome registry","volume":"12","author":"Clemens","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0520","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamacardio.2021.4458","article-title":"Clinical and functional characterization of ryanodine receptor 2 variants implicated in calcium-release deficiency syndrome","volume":"7","author":"Roston","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0525","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003589","article-title":"Provocation testing and therapeutic response in a newly described channelopathy: RyR2 calcium release deficiency syndrome","volume":"15","author":"Ormerod","year":"2022","journal-title":"Circ Genom Precis Med"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0530","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2025.06.002_bb0535","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0540","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacc.2023.12.015","article-title":"Phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathies","volume":"83","author":"Bariani","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2025.06.002_bb0545","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/eurheartj\/ehv387","article-title":"Approach to family screening in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"37","author":"te Riele","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0550","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacep.2021.12.002","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0555","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"9","key":"10.1016\/j.pcad.2025.06.002_bb0560","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41431-018-0169-4","article-title":"Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database","volume":"26","author":"Hall","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0565","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003097","article-title":"Cadherin 2-related arrhythmogenic cardiomyopathy: prevalence and clinical features","volume":"14","author":"Ghidoni","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0570","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced","volume":"24","author":"Te Riele","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"10.1016\/j.pcad.2025.06.002_bb0575","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41569-019-0200-7","article-title":"Molecular mechanisms of arrhythmogenic cardiomyopathy","volume":"16","author":"Austin","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"10.1016\/j.pcad.2025.06.002_bb0580","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021370","article-title":"Endomyocardial biopsy: the forgotten piece in the arrhythmogenic cardiomyopathy puzzle","volume":"10","author":"Casella","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0585","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"Europace"},{"issue":"15","key":"10.1016\/j.pcad.2025.06.002_bb0590","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","article-title":"Evidence from family studies for autoimmunity in arrhythmogenic right ventricular cardiomyopathy: associations of circulating anti-heart and anti-intercalated disk autoantibodies with disease severity and family history","volume":"141","author":"Caforio","year":"2020","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.pcad.2025.06.002_bb0595","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.pcad.2025.06.002_bb0600","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2025.06.002_bb0605","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.hrthm.2020.09.015","article-title":"Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC task force criteria","volume":"18","author":"Gasperetti","year":"2021","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.pcad.2025.06.002_bb0610","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jacep.2020.02.008","article-title":"Electroanatomical voltage mapping to distinguish right-sided cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Hoogendoorn","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.pcad.2025.06.002_bb0615","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.hlc.2019.12.007","article-title":"Exercise and arrhythmogenic right ventricular cardiomyopathy","volume":"29","author":"Prior","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0620","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.hrthm.2023.08.035","article-title":"Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy","volume":"20","author":"Sampognaro","year":"2023","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0625","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jacc.2023.05.005","article-title":"Individualized family screening for arrhythmogenic right ventricular cardiomyopathy","volume":"82","author":"Muller","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0630","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003530","article-title":"Arrhythmogenic right ventricular cardiomyopathy prevalence and arrhythmic outcomes in at-risk family members: a systematic review and meta-analysis","volume":"15","author":"Sharma","year":"2022","journal-title":"Circ Genom Precis Med"},{"issue":"23","key":"10.1016\/j.pcad.2025.06.002_bb0635","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2025.06.002_bb0640","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0645","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008509","article-title":"Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration","volume":"14","author":"Cadrin-Tourigny","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"32","key":"10.1016\/j.pcad.2025.06.002_bb0650","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/eurheartj\/ehac289","article-title":"Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator","volume":"43","author":"Jorda","year":"2022","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.pcad.2025.06.002_bb0655","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/eurheartj\/ehac235","article-title":"Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator","volume":"43","author":"Protonotarios","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2025.06.002_bb0660","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003589","article-title":"Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy","volume":"9","author":"Hodgkinson","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.06.002_bb0665","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad312","article-title":"Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"25","author":"Gasperetti","year":"2023","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.pcad.2025.06.002_bb0670","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.122.060866","article-title":"Programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy: a multinational study","volume":"146","author":"Gasperetti","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2025.06.002_bb0675","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ehjci\/jeac030","article-title":"Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Bourfiss","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0680","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ehjci\/jead174","article-title":"The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Kirkels","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0685","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/europace\/euaa105","article-title":"Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients","volume":"22","author":"Wang","year":"2020","journal-title":"Europace"},{"issue":"30","key":"10.1016\/j.pcad.2025.06.002_bb0690","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.pcad.2025.06.002_bb0695","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008782","article-title":"Subcutaneous implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a transatlantic experience","volume":"7","author":"Orgeron","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.pcad.2025.06.002_bb0700","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/eurheartj\/ehad799","article-title":"Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.pcad.2025.06.002_bb0705","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","article-title":"Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC program","volume":"18","author":"Daimee","year":"2021","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.pcad.2025.06.002_bb0710","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","article-title":"Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy","volume":"2","author":"Kyriakopoulou","year":"2023","journal-title":"Nat Cardiovasc Res"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:50:14Z","timestamp":1776833414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062025000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":142,"alternative-id":["S0033062025000799"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2025.06.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC)","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}